Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadim Mahmud

Showing results (191-200 of 239) with videos related to

Pageof 24
Sort By:
Cancer Immunology, Immunotherapy : CII|November 12, 2005
Induction of specific T cell immunity in patients with prostate cancer by vaccination with PSA146-154 peptideSupriya Perambakam, Sigrun Hallmeyer, Samarth Reddy, et al.
Alimentary Pharmacology & Therapeutics|July 30, 2020
Patients with severe acute-on-chronic liver failure are disadvantaged by model for end-stage liver disease-based organ allocation policyVinay Sundaram, Parth Shah, Nadim Mahmud, et al.
Journal of Cardiac Failure. Intersections|April 8, 2026
Antihypertensive Dosing During Mavacamten Therapy for Obstructive Hypertrophic CardiomyopathyNosheen Reza, Nadim Mahmud, Melissa A Austin, et al.
JACC. Heart Failure|October 1, 2025
Hypertension in Patients With Obstructive Hypertrophic Cardiomyopathy Treated With MavacamtenNosheen Reza, Nadim Mahmud, Melissa A Austin, et al.
Journal of Cardiac Failure|February 3, 2026
Association between Baseline Hypertension and Longitudinal Functional Status in Obstructive Hypertrophic Cardiomyopathy Treated with MavacamtenNosheen Reza, Nadim Mahmud, Melissa A Austin, et al.
Transfusion|March 21, 2022
Cryopreserved hematopoietic stem/progenitor cells stability program-development, current status and recommendations: A brief report from the AABB-ISCT joint working group cellular therapy product stability project teamRonit Reich-Slotky, Ljiljana V Vasovic, Kevin J Land, et al.
British Journal of Clinical Pharmacology|April 15, 2020
Development of a method for clinical pharmacokinetic testing to allow for targeted Melphalan dosing in multiple myeloma patients undergoing autologous transplantKaren Sweiss, Bhaskar Vemu, Craig C Hofmeister, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 19, 2017
T Cell-Mediated Rejection of Human CD34<sup>+</sup> Cells Is Prevented by Costimulatory Blockade in a Xenograft ModelAnnie L Oh, Dolores Mahmud, Benedetta Nicolini, et al.
Cytotherapy|March 25, 2022
Cryopreserved hematopoietic stem/progenitor cells stability program-development, current status and recommendations: A brief report from the AABB-ISCT joint working group cellular therapy product stability project teamRonit Reich-Slotky, Ljiljana V Vasovic, Kevin J Land, et al.
Cytotherapy|October 27, 2025
Beyond body weight: investigating the impact of body surface area on graft CD34+ cell dosing: a single-center experienceSeungwon An, Youngmin Park, Celeste Mora, et al.
Pageof 24

Showing results (191-200 of 239) with videos related to

Sort By:
Pageof 24
Cancer Immunology, Immunotherapy : CII|November 12, 2005
Induction of specific T cell immunity in patients with prostate cancer by vaccination with PSA146-154 peptideSupriya Perambakam, Sigrun Hallmeyer, Samarth Reddy, et al.
Alimentary Pharmacology & Therapeutics|July 30, 2020
Patients with severe acute-on-chronic liver failure are disadvantaged by model for end-stage liver disease-based organ allocation policyVinay Sundaram, Parth Shah, Nadim Mahmud, et al.
Journal of Cardiac Failure. Intersections|April 8, 2026
Antihypertensive Dosing During Mavacamten Therapy for Obstructive Hypertrophic CardiomyopathyNosheen Reza, Nadim Mahmud, Melissa A Austin, et al.
JACC. Heart Failure|October 1, 2025
Hypertension in Patients With Obstructive Hypertrophic Cardiomyopathy Treated With MavacamtenNosheen Reza, Nadim Mahmud, Melissa A Austin, et al.
Journal of Cardiac Failure|February 3, 2026
Association between Baseline Hypertension and Longitudinal Functional Status in Obstructive Hypertrophic Cardiomyopathy Treated with MavacamtenNosheen Reza, Nadim Mahmud, Melissa A Austin, et al.
Transfusion|March 21, 2022
Cryopreserved hematopoietic stem/progenitor cells stability program-development, current status and recommendations: A brief report from the AABB-ISCT joint working group cellular therapy product stability project teamRonit Reich-Slotky, Ljiljana V Vasovic, Kevin J Land, et al.
British Journal of Clinical Pharmacology|April 15, 2020
Development of a method for clinical pharmacokinetic testing to allow for targeted Melphalan dosing in multiple myeloma patients undergoing autologous transplantKaren Sweiss, Bhaskar Vemu, Craig C Hofmeister, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 19, 2017
T Cell-Mediated Rejection of Human CD34<sup>+</sup> Cells Is Prevented by Costimulatory Blockade in a Xenograft ModelAnnie L Oh, Dolores Mahmud, Benedetta Nicolini, et al.
Cytotherapy|March 25, 2022
Cryopreserved hematopoietic stem/progenitor cells stability program-development, current status and recommendations: A brief report from the AABB-ISCT joint working group cellular therapy product stability project teamRonit Reich-Slotky, Ljiljana V Vasovic, Kevin J Land, et al.
Cytotherapy|October 27, 2025
Beyond body weight: investigating the impact of body surface area on graft CD34+ cell dosing: a single-center experienceSeungwon An, Youngmin Park, Celeste Mora, et al.
Pageof 24